Health Condition 1: M109- Gout, unspecified
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients presenting with the clinical features of Vatarakta (sandhi shotha(swelling), sandhi shola(pain), sparsh asahatvam (tenderness), twak vaivarnya(discolouration of skin), raga(redness), vidaha(burning sensation), stabdhata(stiffness)) 2.Patients either sex between age group of 21-60 yrs. 3.Patients showing the Serum uric acid level 7 -10mg/dl.
Exclusion criteria
Exclusion criteria: 1.Uncontrolled Diabetes and uncontrolled HTN 2.Subjects pre-diagnosed with autoimmune and infective disease of joints. E.g. tuberculous arthritis 3.Malignancy 4.Genetic Disorder e.g. Duchene muscular dystrophy 5.Pregnant and lactating women 6.History of hypersensitivity to any of the trial drug ingredient.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| •Improvement in the signs & symptoms (sandhi shotha(swelling)sandhi shola(pain), sparsh asahatvam (tenderness), twak vaivarnya(discolouration of skin), raga(redness), vidaha(burning sensation), stabdhata(stiffness)) of Vatarakta (Chronic Gout).Timepoint: BASELINE AFTER 6 WEEKS AFTER 12 WEEKS | — |
Secondary
| Measure | Time frame |
|---|---|
| Reduction in the level of serum uric acid in the patients having Vatarakta (Chronic Gout). (approx 25% improvement is expected) Improvement in the quality of life of the patient.Timepoint: BASELINE AFTER 6 WEEKS AFTER 12 WEEKS | — |
Countries
India
Contacts
ALL INDIA INSTITUTE OF AYURVEDA